Location: Boston MA, Providence RI, Montreal, Fairfax VA, Toronto,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05797168
Phase1, Phase2, Recruiting
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
for
Asthma
Location: Maspeth NY, Toms River NJ, Philadelphia PA, Kingwood WV,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06932263
Phase2, Recruiting
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
for
Systemic Lupus Erythematosus
Location: Wilmington NC
Sponsor: AstraZeneca
Sex: Female
Age: 0+
Code: NCT06659029
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of AZD0754 in Participants With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: New York NY, Hackensack NJ, Philadelphia PA, Tampa FL,
Sponsor: AstraZeneca
Sex: Male
Age: 18 - 70+
Code: NCT06267729
Phase1, Phase2, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
for
Asthma
Location: Boston MA, Hawthorne NY, Staten Island NY,
Sponsor: AstraZeneca
Sex: All
Age: 5 - 11
Code: NCT06023589
Phase3, Recruiting
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
for
Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma,
Location: Boston MA, New York NY, Philadelphia PA, Miami FL,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT06137144
Phase1, Phase2, Recruiting
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
for
Hepatocellular Carcinoma
Location: St Louis MO, Houston TX, Los Angeles CA
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06795022
Phase1, Phase2, Recruiting
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
for
Metastatic Non-small Cell Lung Cancer
Location: Boston MA, Quebec, The Bronx NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06417814
Phase3, Recruiting
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
for
Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer,
Location: Boston MA, Commack NY, Baltimore MD, Ottawa, Toronto,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05123482
Phase1, Phase2, Recruiting
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
for
ER+ HER2- Advanced Breast Cancer,
Location: Providence RI, Nashville TN, St Louis MO, Houston TX
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06188520
Phase1, Phase2, Recruiting
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
for
Gastric Cancer
Location: New York NY, Grand Rapids MI, Baton Rouge LA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05702229
Phase2, Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)